JAK-STAT signaling is a crucial transducer in cardiomyocytes hypoxia injury (60), cancer (61), hematopoiesis and leukemia (62), rheumatoid arthritis (63), acute lung injury (64), central nervous system disorders (65), and obesity and diabetes (66). This evidence concerns the gene SOAT1 and obesity disorder.